Latest California Healthline Stories
CT Scans For Minor Injuries On A Rapid Rise In California Emergency Rooms
Researchers say they’re reporting the facts, but not taking a stand on CT “overuse.”
Mortgages For Expensive Health Care? Some Experts Think It Can Work.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
Marin Group Uses Local Data To Fight Fatal Prescription Overdoses
New organizations are collecting fresh data to address current health problems.
Contratistas Agrícolas Se Resisten A Requisitos Del Obamacare
La ley federal de salud está poniendo a los agricultores en una situación difícil. Muchos contratistas que suministran trabajadores tienen que ofrecer cobertura de salud. El seguro es costoso, y los contratistas se preocupan sobre las consecuencias para la inmigración.
Big Insurance Deal Under Scrutiny in California
Anthem and Cigna must persuade insurance commissioner Dave Jones their proposed $54 billion mega-merger is a good thing.
Algunos expertos dicen que el aumento del 86 por ciento en las hospitalizaciones psiquiátricas, desde el 2007, significa una seria deficiencia en el cuidado preventivo; otros creen que haber reducido el estigma ha llevado a los jóvenes a aceptar ayuda.
Fantasy Sports Fueling A Rise In Online Gambling Addiction
Seeing more problem gamblers than ever before, the state is investing in education, training and prevention.
Device Maker Olympus Hiked Prices For Scopes As Superbug Infections Spread
The device manufacturer had a close relationship with Ronald Reagan UCLA Medical Center in Los Angeles — until its scopes were linked to infections and the company raised the price for new ones by 28 percent.
More Sickle Cell Patients Survive, But Care Is Hard To Find For Adults
For many years, most people with sickle cell died in childhood or adolescence, and the condition remained in the province of pediatrics. During the past two decades, advances in routine care have allowed many people to live into middle age and beyond, but barriers to care remain.
Pharmaceutical Company Has Hiked Price On Aid-In-Dying Drug
Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.